Sampsonione F suppresses adipogenesis via activating p53 pathway during the mitotic clonal expansion progression of adipocyte differentiation
Related Experiment Video
Updated: Sep 24, 2025

Author Spotlight: Semi-Automated Isolation of the Stromal Vascular Fraction from Murine White Adipose Tissue Using a Tissue Dissociator
Published on: May 19, 2023
Dao-Wei Liu1, Yan-Song Ye2, Chao-Guang Huang1
1Key Laboratory of Medicinal Chemistry for Natural Resource, Ministry of Education, Yunnan Provincial Center for Research & Development of Natural Products, School of Chemical Science and Technology, Yunnan University, Kunming, 650091, PR China.
Abstract:
The abnormal proliferation and hypertrophy of adipocytes mediate the expansion of adipose tissue and then cause obesity-related diseases. Theoretically, an approach for preventing and curing obesity is to inhibit cell proliferation during the mitotic clonal expansion (MCE) progression of adipocyte differentiation. Polycyclic polyprenylated acylphloroglucinols (PPAPs) are mainly found from Hypericum and Garcinia genus, which have been reported to have various biological activities such as anti-depressant, anti-oxidant, and anti-tumor. Previously, our group has reported that adamantane-type PPAPs exhibited blunting activity in adipogenesis. In this study, another six adamantane PPAPs were screened to investigate their anti-adipogenesis activities and then discussed the structure-activity relationship. Particularly, sampsonione F, one of the PPAPs dramatically suppressed adipogenesis dose-dependently in vitro, along with decreased expressions of C/EBPβ, C/EBPα, PPARγ, FABP4, and FAS. Moreover, sampsonione F upregulated the expression of p27 by activating p53 pathway and then downregulated the expressions of key regulators during G1/S phase arrest. Our data support that sampsonione F suppressed adipogenesis by activating p53 pathway, regulating cyclins, and resulting in G1/S phase arrest during the MCE progression of adipogenesis. This work provides a new adamantane-type PPAPs in the regulation of adipogenesis and extends our knowledges on the mechanism of the type PPAPs in regulation of adipogenesis.
Insights
Sampsonione F, a novel adamantane-type polycyclic polyprenylated acylphloroglucinol (PPAP), effectively inhibits adipogenesis by arresting cell cycle progression during mitotic clonal expansion (MCE). This compound offers a potential therapeutic strategy for obesity by targeting key regulators of adipocyte differentiation.
Area of Science:
- Biochemistry
- Cell Biology
- Pharmacology
Background:
- Obesity arises from abnormal adipocyte proliferation and hypertrophy, driving related diseases.
- Inhibiting adipocyte mitotic clonal expansion (MCE) offers a theoretical strategy for obesity prevention and treatment.
- Polycyclic polyprenylated acylphloroglucinols (PPAPs), particularly adamantane-type, have shown potential in modulating adipogenesis.
Purpose of the Study:
- To screen novel adamantane-type PPAPs for anti-adipogenic activity.
- To investigate the structure-activity relationship of these compounds.
- To elucidate the mechanism of action for potent anti-adipogenic PPAPs.
Main Methods:
- Screening of six adamantane PPAPs for anti-adipogenesis effects in vitro.
- Dose-dependent assessment of sampsonione F's impact on adipogenesis.
- Analysis of gene and protein expression related to adipogenesis and cell cycle regulation (C/EBPβ, C/EBPα, PPARγ, FABP4, FAS, p27, p53, cyclins).
Main Results:
- Sampsonione F significantly suppressed adipogenesis in a dose-dependent manner.
- It decreased the expression of key adipogenic markers (C/EBPβ, C/EBPα, PPARγ, FABP4, FAS).
- Sampsonione F upregulated p27 expression via p53 activation, leading to G1/S phase arrest and downregulation of cell cycle regulators.
Conclusions:
- Sampsonione F inhibits adipogenesis by activating the p53 pathway and inducing G1/S phase arrest during MCE.
- This study identifies a new adamantane-type PPAP with significant anti-adipogenic properties.
- The findings enhance understanding of PPAP mechanisms in regulating adipogenesis and offer potential therapeutic leads for obesity.
More Related Videos
Related Concept Videos
Abnormal Proliferation
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Cell Specific Gene Expression
Negative Regulator Molecules

